US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ashland

49.10

-1.1000-2.19%

Post-market: 49.100.00000.00%17:34 EDT

Volume:544.34K

Turnover:26.91M

Market Cap:2.24B

PE:-20.25

High:50.21

Open:49.73

Low:49.10

Close:50.20

Loading ...

Overview Company News Filings

Press Release: Prelude Therapeutics Reports Full Year 2024 Financial Results and Provides Program Outlook for 2025

Seaport Global downgrades Ashland (ASH) to a Hold

Press Release: Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024

Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Ashland Cut to Neutral From Buy by Seaport Global

Seaport Research downgrades chemicals trio to Neutral

Seaport Global Securities Downgrades Ashland to Neutral From Buy

MT Newswires Live

Syndax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibitor

BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Ashley Services Group First Half 2025 Earnings: EPS: AU$0.013 (vs AU$0.007 in 1H 2024)

Simply Wall St.

Geron Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Beam Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Reiterates Anticipated Catalysts

Returns On Capital At Ashley Services Group (ASX:ASH) Paint A Concerning Picture

Simply Wall St.

Ashland Inc. (ASH): Among the Most Expensive Stocks Insiders Are Buying Recently

Ashley Services Group Insiders Added AU$859.6k Of Stock To Their Holdings

Simply Wall St.

Ashland (ASH) Slid due to Competitive Pressures

Bear Of The Day: GSK PLC (GSK)

Top Executives Make Bold Moves in Ashland Stock!

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ASH/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASH\",,,,,undefined,":{"symbol":"ASH","market":"US","secType":"STK","nameCN":"Ashland","latestPrice":49.1,"timestamp":1750190400000,"preClose":50.2,"halted":0,"volume":544342,"hourTrading":{"tag":"盘后","latestPrice":49.1,"preClose":49.1,"latestTime":"17:34 EDT","volume":19722,"amount":968349.21,"timestamp":1750196096043},"delay":0,"floatShares":45123636,"shares":45694535,"eps":-2.425052,"marketStatus":"Closed","change":-1.1,"latestTime":"06-17 16:00:00 EDT","open":49.73,"high":50.21,"low":49.1,"amount":26906125.58053,"amplitude":0.022112,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.425052,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750233600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":50.2,"dividendRate":0.032994,"preHourTrading":{"tag":"盘前","latestPrice":50.8,"preClose":50.22,"latestTime":"08:09 EDT","volume":3,"amount":152.39999999999998,"timestamp":1750162144796},"postHourTrading":{"tag":"盘后","latestPrice":49.1,"preClose":49.1,"latestTime":"17:34 EDT","volume":19722,"amount":968349.21,"timestamp":1750196096043},"volumeRatio":1.049172,"impliedVol":0.4534,"impliedVolPercentile":0.884},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASH\",,,,,undefined,":{"symbol":"ASH","floatShares":45123636,"roa":"2.28%","roe":"-3.02%","lyrEps":3.448979,"volumeRatio":1.049172,"shares":45694535,"dividePrice":1.62,"high":50.21,"amplitude":0.022112,"preClose":50.2,"low":49.1,"week52Low":45.21,"pbRate":"0.88","psRate":"1.15","week52High":98.99,"institutionHeld":0.8513,"latestPrice":49.1,"eps":-2.425052,"divideRate":0.032994,"volume":544342,"delay":0,"ttmEps":-2.425052,"open":49.73,"prevYearClose":71.46,"prevWeekClose":49.59,"prevMonthClose":49.51,"prevQuarterClose":59.29,"fiveDayClose":53.02,"twentyDayClose":52.33,"sixtyDayClose":56.45},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ASH\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518247175","title":"Press Release: Prelude Therapeutics Reports Full Year 2024 Financial Results and Provides Program Outlook for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2518247175","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518247175?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:30","pubTimestamp":1741606200,"startTime":"0","endTime":"0","summary":"PRT3789 has demonstrated clinical proof-of-concept that selectively degrading SMARCA2 is generally safe and has monotherapy anti-tumor activity in patients with SMARCA4-deficient, non-small cell lung , gastric and esophageal cancer. PRT3789 monotherapy dose escalation enrollment is nearing completion and dose escalation in combination with docetaxel continues with plans to present additional results from both cohorts in the second half of 2025. Continued Vaddi, \"We look forward to sharing data throughout the year both from our ongoing dose escalation and combination studies with PRT3789, and the first clinical data from our ongoing clinical trial of our once-daily oral SMARCA2 degrader, PRT7732. Lastly, our research and development organization was incredibly productive throughout 2024 continuing our mission to deliver new precision oncology medicines for patients with significant unmet need. We anticipate providing an update on our emerging discovery pipeline in the first half of 2025","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1929549753.HKD","LU0320765646.SGD","IE00BSNM7G36.USD","LU0965508806.USD","SG9999014567.USD","LU0208291251.USD","SG9999001176.SGD","LU1699723380.USD","LU2361045086.USD","LU0238689110.USD","BK4139","LU0265550359.USD","PRLD","R","LU1989772840.SGD","LU1291159041.SGD","LU1941712348.USD","LU1066051811.HKD","BK4007","LU1037948897.HKD","LU2023250843.SGD","IE00BLSP4452.SGD","IE00B4R5TH58.HKD","LU1934455863.HKD","IE000M9KFDE8.USD","SGXZ57979304.SGD","SG9999014575.USD","LU1974910355.USD","SG9999001176.USD","LU1093756325.SGD","LU2461242641.AUD","ASH","IE0009355771.USD","SG9999015358.SGD","SG9999002232.USD","LU2463526074.USD","LENZ","IE00B1BXHZ80.USD","LU2361044865.SGD","LU2112291526.USD","LU1917777945.USD","LU1066051225.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","MRK","LU0203345920.USD","IE00BLSP4239.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","SG9999002224.SGD"],"gpt_icon":0},{"id":"2517444683","title":"Seaport Global downgrades Ashland (ASH) to a Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2517444683","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517444683?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:36","pubTimestamp":1741444614,"startTime":"0","endTime":"0","summary":"Ashland (ASH – Research Report) received a Hold rating and price target from Seaport Global analyst Michael Harrison CFA today. The company’s share...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/seaport-global-downgrades-ashland-ash-to-a-hold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/seaport-global-downgrades-ashland-ash-to-a-hold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASH"],"gpt_icon":0},{"id":"2517666118","title":"Press Release: Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2517666118","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517666118?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:00","pubTimestamp":1741294800,"startTime":"0","endTime":"0","summary":"-- DLL3 targeting Radio-DARPin MP0712 to enter first-in-human study in 2025,-- Strategic partnership with Orano Med on Radio-DARPins now expanded to ten. -- MP0533 Phase 1/2a clinical data show improved response rate and depth in. ongoing cohort, additional dosing optimization planned; data expected. and short-term deposits at end of 2024, expected to support operations. \"Molecular Partners has made significant progress through 2024, setting us up for a number of key value inflection points. The potential of our Radio-DARPins is now well recognized in the field. In addition, we are advancing our next-generation immuno-oncology programs, including multispecific and Switch-DARPin T cell engagers\", said Patrick Amstutz, Ph.D., Chief Executive Officer of Molecular Partners.The Investigational New Drug  application for MP0712, a  Pb Radio-DARPin therapy  candidate targeting the tumor-associated protein delta-like ligand 3  and co-developed with Orano Med, is in preparation. Dialogue with th","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BK4109","BK4080","IE00BMG7P926.USD","IE00BMG7P694.USD","LU1093756168.USD","BK4539","SWCH","LU2463526074.USD","BK4139","BK4231","BK4513","SITC","BK4566","IE00BMG7P819.SGD","MOLN","IE00BMG7P587.USD","BK4116","ASH","TRP","TAT","BK4144"],"gpt_icon":0},{"id":"2517792973","title":"Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2517792973","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517792973?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:01","pubTimestamp":1741208460,"startTime":"0","endTime":"0","summary":"Phase 1 Dose Expansion Initiated for FT819 Off-the-Shelf CAR T-cell Product Candidate with Fludarabine-free Conditioning in Moderate-to-Severe SLE. Completed Type D Meeting with FDA to Enable FT819 Off-the-Shelf CAR T-cell Dose Expansion in Additional B Cell-mediated Autoimmune Diseases. First FT819 Off-the-Shelf CAR T-cell Patient Treated without Conditioning Chemotherapy as Add-on to Maintenance Therapy in SLE. Phase 1 Dose Expansion Initiated for SLE using Flu-free Conditioning Regimen. Based on clinical data from the first three patients treated with FT819 in its ongoing multi-center, Phase 1 clinical trial for moderate-to-severe systemic lupus erythematosus  , the Company has initiated dose expansion in up to 10 patients at 360 million cells. The dose expansion stage is designed to evaluate the safety and efficacy of a fludarabine -free conditioning regimen, consisting of either bendamustine alone or cyclophosphamide alone, followed by a single dose of FT819. The Company is also a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fate-therapeutics-reports-fourth-quarter-210100391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU2463526074.USD","SITC","FATE","BK4112","CAR","IE00B66KJ199.SGD","BK4022","IE00B19Z4B17.USD","BK4077","IE0031619046.USD","LU2065731478.USD","BK4109","IE00B7SZL793.SGD","IIM","SLE","BK4006","CRS","BK4230","BK4231","BK4080","ASH","TRAC"],"gpt_icon":0},{"id":"2517912530","title":"Ashland Cut to Neutral From Buy by Seaport Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2517912530","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517912530?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:46","pubTimestamp":1741182360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ASH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 05, 2025 08:46 ET (13:46 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASH"],"gpt_icon":0},{"id":"2517191479","title":"Seaport Research downgrades chemicals trio to Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2517191479","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517191479?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:37","pubTimestamp":1741181860,"startTime":"0","endTime":"0","summary":"As previously reported, Seaport Research downgraded Ashland (ASH), H.B. Fuller (FUL) and PPG (PPG), all to Neutral from Buy, and removed the firm’s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-research-downgrades-chemicals-trio-to-neutral?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-research-downgrades-chemicals-trio-to-neutral?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU2463526074.USD","FUL","BK4109","PPG","ASH","BK4504","BK4585"],"gpt_icon":0},{"id":"2517919454","title":"Seaport Global Securities Downgrades Ashland to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517919454","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517919454?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:02","pubTimestamp":1741179765,"startTime":"0","endTime":"0","summary":"Ashland (ASH) has an average rating of overweight and mean price target of $84, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ASH"],"gpt_icon":0},{"id":"2516760687","title":"Syndax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2516760687","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516760687?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:01","pubTimestamp":1741003260,"startTime":"0","endTime":"0","summary":"– $7.7 million in Revuforj  net product revenue in initial five weeks of launch –。– Launched Niktimvo  in the U.S. in late January, in partnership with Incyte –。–sNDA filing for revumenib in R/R mNPM1 AML expected in 2Q25 based on positive pivotal data from AUGMENT-101 trial –。–$692.4 million in cash, cash equivalents and investments expected to fund the company to profitability –。NEW YORK, March 03, 2025  -- Syndax Pharmaceuticals , a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today reported its financial results for the fourth quarter and full year endedDecember 31, 2024, and provided a business update.Reported additional positive results from a post-hoc efficacy analysis of all 77 R/R mNPM1 AML patients who met the efficacy evaluabl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/syndax-reports-fourth-quarter-full-120100660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ORR","HSTC","LU1699723380.USD","BK4533","BK4139","LU2355687059.USD","MSS","LU0985320562.USD","LU0266512127.USD","CR","BK4585","CRC","LU0456854461.SGD","BK4161","ASH","BK4113","BK4109","LU1571399168.USD","BK4588","BK4213","ALL","SNDX","BK4107","LU2463526074.USD"],"gpt_icon":0},{"id":"2514324925","title":"Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2514324925","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514324925?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:14","pubTimestamp":1740748440,"startTime":"0","endTime":"0","summary":"The positive opinion is based on results from the Phase 3 BRUIN CLL-321 trial, recently presented at the 2024 American Society of Hematology Annual Meeting. BRUIN CLL-321 is the first randomized Phase 3 study in CLL ever conducted exclusively in patients previously treated with a BTK inhibitor. The positive opinion is supported by data from the BRUIN CLL-321 clinical trial, the first randomized Phase 3 study in CLL ever conducted exclusively in patients previously treated with a BTK inhibitor. The study's primary endpoint of progression-free survival  was met at the prespecified time of final analysis , based on independent review committee  assessment, demonstrating pirtobrutinib was superior to investigator's choice of idelalisib plus rituximab  or bendamustine plus rituximab , both global standards of care.1 At an updated analysis , pirtobrutinib reduced therisk of disease progressionor death by 46% compared to IdelaR or BR, consistent with the primary analysis.PFS results were cons","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/lillys-jaypirca-pirtobrutinib-recommended-chmp-131400700.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lillys-jaypirca-pirtobrutinib-recommended-chmp-131400700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4516","LU2491050071.SGD","LU2237443465.HKD","BK4226","LU1069344957.HKD","SG9999001176.USD","LU2461242641.AUD","LU2237443978.SGD","IE0002141913.USD","LU0354030511.USD","LU0471298777.SGD","PRO","LU1023059063.AUD","ASH","ORR","SG9999015986.USD","IE0009355771.USD","BK4585","LU0640476718.USD","LU1974910355.USD","BK4109","BNTX","LU1814569148.SGD","LU2237443382.USD","LU2265009873.SGD","LU0203202063.USD","FL","BK4599","BK4588","BR","PFS","LU0882574139.USD","BK4094","LU1720051108.HKD","LU0238689110.USD","LU2602419157.SGD","LU2211815571.USD","LU0390134368.USD","OS","LU2361045086.USD","LU2237443622.USD","LU1267930730.SGD","IE00BK4W5L77.USD","LLY","IE00BJT1NW94.SGD","BK4533","LU0203201768.USD","LU1061106388.HKD","LU2063271972.USD","CHMP"],"gpt_icon":1},{"id":"2514877680","title":"BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2514877680","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514877680?lang=en_us&edition=fundamental","pubTime":"2025-02-27 19:00","pubTimestamp":1740654000,"startTime":"0","endTime":"0","summary":"Total global revenues of $1.1 billion and $3.8 billion for the fourth quarter and full year, increases of 78% and 55%, respectively; narrowed GAAP operating loss and achieved full-year positive non-GAAP operating income. Global BRUKINSA revenues of $828 million and $2.6 billion for the fourth quarter and full year, increases of 100% and 105%, respectively; progressed pivotal-stage programs for BCL2 inhibitor sonrotoclax and BTK CDAC BGB-16673. Advanced six and 13 New Molecular Entities  into the clinic in the fourth quarter and full year, respectively; anticipate multiple data readouts for innovative solid tumor programs in 1H 2025. Full year 2025 revenue guidance of $4.9 billion to $5.3 billion, reaffirm anticipated positive GAAP operating income and cash flow generation from operations in 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beigene-announces-fourth-quarter-full-110000380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4201","LU0053666078.USD","BK4588","BK4585","BK4109","LU2463526074.USD","EC","L","ASH","BK4107","ONC","BK4139"],"gpt_icon":0},{"id":"2514845114","title":"Ashley Services Group First Half 2025 Earnings: EPS: AU$0.013 (vs AU$0.007 in 1H 2024)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514845114","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514845114?lang=en_us&edition=fundamental","pubTime":"2025-02-27 08:45","pubTimestamp":1740617158,"startTime":"0","endTime":"0","summary":"Ashley Services Group ( ASX:ASH ) First Half 2025 Results Key Financial Results Revenue: AU$266.2m (down 8.5% from 1H...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9612011-choice1-main-header/1585186854967","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612011-choice1-main-header/1585186854967"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/commercial-services/asx-ash/ashley-services-group-shares/news/ashley-services-group-first-half-2025-earnings-eps-au0013-vs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ASH"],"gpt_icon":0},{"id":"2514483443","title":"Geron Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2514483443","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514483443?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:30","pubTimestamp":1740573000,"startTime":"0","endTime":"0","summary":"Achieved $47.5 million in RYTELO  net product revenue in Q4 2024 and $76.5 million since commercial launch at the end of June 2024, following FDA approval. Expect to reach profitability without additional financing if current internal sales and operating expenses expectations are met. FOSTER CITY, Calif., February 26, 2025----Geron Corporation , a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today reported financial results for the fourth quarter and full year 2024 and recent business highlights.Continued execution on U.S. commercial launch, with net product revenue for RYTELO  of $47.5 million in the fourth quarter of 2024 and $76.5 million since launch at the end of June 2024, following approval by the U.S. Food and Drug Administration .Presented new data at the 66th American Society for Hematology  Annual Meeting in December 2024, including analyses of IMerge Phase 3 data suggesting clinical activity o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/geron-corporation-reports-fourth-quarter-123000150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CHMP","BK4097","BK4109","LU2463526074.USD","OS","ASH","GERN","BK4087","BK4139"],"gpt_icon":0},{"id":"2514728096","title":"Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514728096","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514728096?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:00","pubTimestamp":1740488400,"startTime":"0","endTime":"0","summary":"Top-line results from SUMMIT trial in NonAdvSM patients expected July 2025. APEX trial enrollment in AdvSM patients complete; top-line results expected in 2H 2025. $312 million sufficient to fund operations well past clinical readouts, into late 2026; includes gross proceeds from ATM sale in February 2025. WALTHAM, Mass. and BOULDER, Colo., Feb. 25, 2025  -- Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, today provided a business update and reported financial results for the fourth quarter and full year of 2024.52% ORR per mIWG criteria, including 83% ORR for patients receiving 100 mg BID. 88% ORR per PPR criteria, including 100% ORR for patients receiving 100 mg BID. Cogent’s internally-developed pan-KRAS inhibitor demonstrated picomolar  activity across KRAS mutations with selectivity over H/NRAS leading to potential advantages versus other molecules in the class. Following oral administration, CGT6737 dem","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cogent-biosciences-reports-recent-business-130000215.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2360107325.USD","BK4213","LU2463526074.USD","COGT","LU2298322129.HKD","LU0348723411.USD","LU1854103824.USD","LU1861215975.USD","BK4089","ON","LU1861219969.SGD","BK4141","BK4505","LU0124384867.USD","LU1861220033.SGD","LU1670628061.USD","BK4109","LU1861214812.USD","LU1720051017.SGD","BK4585","LU1978683503.SGD","BK4605","CCOI","BK4139","LU1854104046.USD","LU1548497426.USD","LU1670627923.USD","BK4532","ASH","IE00BZ199S13.USD","LU1720051108.HKD","LU0724618433.USD","TSS","LU2357305700.SGD","SM","BK4512","IE00BD6J9T35.USD","BK4588"],"gpt_icon":0},{"id":"2514093342","title":"Beam Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Reiterates Anticipated Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2514093342","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514093342?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:00","pubTimestamp":1740484800,"startTime":"0","endTime":"0","summary":"Enrollment Target for Adult Sickle Cell Disease Patients Achieved in BEACON Trial ofBEAM-101; Dosing of 30 Patients and Updated Data Expected by Mid-2025 Initial Data from Phase 1/2 Trial of BEAM-302 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/25/3031842/0/en/Beam-Therapeutics-Reports-Fourth-Quarter-and-Year-End-2024-Financial-Results-and-Reiterates-Anticipated-Catalysts.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2463526074.USD","ASH","BK4535","BEAM","BK4109","SCD","BK4556","BK4139","BK4505","BK4585","BK4588","LENZ"],"gpt_icon":0},{"id":"2513202131","title":"Returns On Capital At Ashley Services Group (ASX:ASH) Paint A Concerning Picture","url":"https://stock-news.laohu8.com/highlight/detail?id=2513202131","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513202131?lang=en_us&edition=fundamental","pubTime":"2025-02-23 06:03","pubTimestamp":1740261791,"startTime":"0","endTime":"0","summary":"There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. Although, when we looked at Ashley Services Group , it didn't seem to tick all of these boxes.Return On Capital Employed : What Is It?Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income  a company earns on the capital invested in its business. To calculate this metric for Ashley Services Group, this is the formula:. Return on Capital Employed = Earnings Before Interest and Tax  ÷ . Therefore, Ashley Services Group has an ROCE of 14%. That's a relatively normal return on capital, and it's around the 17% generated by the Professional Services industry.Check out our latest analysis for Ashley Services Gro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/returns-capital-ashley-services-group-220311437.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LU2463526074.USD","EBIT","ASH.AU","ASH","BK7057","BK4109"],"gpt_icon":0},{"id":"2513797277","title":"Ashland Inc. (ASH): Among the Most Expensive Stocks Insiders Are Buying Recently","url":"https://stock-news.laohu8.com/highlight/detail?id=2513797277","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513797277?lang=en_us&edition=fundamental","pubTime":"2025-02-22 23:04","pubTimestamp":1740236696,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 11 Most Expensive Stocks Insiders Are Buying Recently.In this article, we are going to take a look at where Ashland Inc.  stands against the other expensive stocks. We previously covered the 10 cheapest stocks insiders are buying recently.The broader market returned around 21% over the past 12 months, and it is also doing well this year. Since the beginning of the year, it has moved 3.45%. As the January effect starts to cool off, we thought it could be useful to look into some of the stocks that insiders have recently not been shy to spend money on. Instead of the standard P/E ratio, today we decided to focus on the average price per share.High-priced stocks are often perceived as more reliable long-term investments due to the belief that their higher price reflects a history of strong performance and lower volatility. While in investing there is not a single rule that guarantees results, taking more factors into account, such as price, insider tradi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ashland-inc-ash-among-most-150456767.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ASH","LU2463526074.USD","BK4109"],"gpt_icon":0},{"id":"2513473512","title":"Ashley Services Group Insiders Added AU$859.6k Of Stock To Their Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2513473512","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513473512?lang=en_us&edition=fundamental","pubTime":"2025-02-22 04:00","pubTimestamp":1740168045,"startTime":"0","endTime":"0","summary":"Multiple insiders secured a larger position in Ashley Services Group Limited ( ASX:ASH ) shares over the last 12...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9612011-choice1-main-header/1585186854967","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612011-choice1-main-header/1585186854967"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/commercial-services/asx-ash/ashley-services-group-shares/news/ashley-services-group-insiders-added-au8596k-of-stock-to-the-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ASH.AU","LU2463526074.USD","ASH","BK4109","BK7057"],"gpt_icon":0},{"id":"2511547627","title":"Ashland (ASH) Slid due to Competitive Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2511547627","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511547627?lang=en_us&edition=fundamental","pubTime":"2025-02-13 21:14","pubTimestamp":1739452475,"startTime":"0","endTime":"0","summary":"Diamond Hill Capital, an investment management company, released its “Small Cap Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In Q4, markets rose unevenly, ending another positive year for markets. Stocks rose generally after the US election, but several lost most or all of their gains before the end of the year. Against this backdrop, the strategy outperformed the Russell 2000 Index in Q4 and for the full year. Relative strength in Q4 was concentrated among industrials holdings outperforming benchmark peers by a wide margin. Additionally, consumer staples and energy holdings also provided relative tailwinds. On the other hand, consumer discretionary holdings were the main cause of strategy’s relative weakness. Even though holdings were quite favorable on an absolute basis, underweight to the technology sector was another headwind in Q4. The strategy returned 0.93% in Q4 and 13.22% in 2024, compared to 0.33% and 11.54% return for Russell 2000 I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ashland-ash-slid-due-competitive-131435784.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4109","ASH","DHIL","LU2463526074.USD"],"gpt_icon":0},{"id":"2509272365","title":"Bear Of The Day: GSK PLC (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272365","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509272365?lang=en_us&edition=fundamental","pubTime":"2025-02-06 20:09","pubTimestamp":1738843740,"startTime":"0","endTime":"0","summary":"GSK PLC  is a Zacks Rank #5  after the company beat the Zacks Consensus Estimate when the last reported. The company is in the healthcare space and there has been a lot of press around changes that the new Trump Administration will be brining.. This article will look at why this stock is a Zacks Rank #5  as it is the Bear of the Day.GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.GSK PLC Sponsored ADR  : Free Stock Analysis Report","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bear-day-gsk-plc-gsk-120900131.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ASH","BK4109","BK4588","LU2463526074.USD","GSK","BK4585","BK4007","BK4532","GSK.UK","LU1829250122.USD"],"gpt_icon":0},{"id":"2508491105","title":"Top Executives Make Bold Moves in Ashland Stock!","url":"https://stock-news.laohu8.com/highlight/detail?id=2508491105","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508491105?lang=en_us&edition=fundamental","pubTime":"2025-02-04 10:02","pubTimestamp":1738634535,"startTime":"0","endTime":"0","summary":"New insider activity at Ashland ( ($ASH) ) has taken place on February 4, 2025. In recent transactions, EVP Guillermo Novo made a significant inves...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executives-make-bold-moves-in-ashland-stock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executives-make-bold-moves-in-ashland-stock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","ASH","LU2463526074.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASH\",params:#limit:5,,,undefined,":[{"date":"2025-05-30","symbol":"ASH","amount":0.415,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-01","defaultRemindTime":1748611800000,"name":"Ashland","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-15","payableDate":"2025-06-01","currency":"USD","dateTimestamp":1748577600000,"payDate":"2025-06-15"},{"market":"US","date":"2025-04-30","symbol":"ASH","fiscalQuarterEnding":"2025/03","expectedEps":1.1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745985600000,"reportTimeType":"post","actualEps":0.99},{"date":"2025-02-28","symbol":"ASH","amount":0.405,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-01","defaultRemindTime":1740753000000,"name":"亚什兰","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-15","payableDate":"2025-03-01","currency":"USD","dateTimestamp":1740718800000,"payDate":"2025-03-15"},{"market":"US","date":"2025-01-28","symbol":"ASH","fiscalQuarterEnding":"2024/12","expectedEps":0.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738040400000,"reportTimeType":"post","actualEps":0.28},{"date":"2024-11-29","symbol":"ASH","amount":0.405,"announcedDate":"2024-11-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-01","defaultRemindTime":1732890600000,"name":"亚什兰","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-15","payableDate":"2024-12-01","currency":"USD","dateTimestamp":1732856400000,"payDate":"2024-12-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASH\",market:\"US\",,,undefined,":[{"executeDate":"2015-08-19","recordDate":"2015-08-21","paymentDate":"2015-09-15","value":0.39,"currency":"USD"},{"executeDate":"2015-11-27","recordDate":"2015-12-01","paymentDate":"2015-12-15","value":0.39,"currency":"USD"},{"executeDate":"2016-02-17","recordDate":"2016-02-19","paymentDate":"2016-03-15","value":0.39,"currency":"USD"},{"executeDate":"2016-06-01","recordDate":"2016-06-03","paymentDate":"2016-06-15","value":0.39,"currency":"USD"},{"executeDate":"2016-08-17","recordDate":"2016-08-19","paymentDate":"2016-09-15","value":0.39,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.3636,"hold":0.3636,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3636,"analysts":11,"updateTime":1746244800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ASH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ASH","date":"2025-06-16","current":-20.053026,"percent":0.156457,"low":-152.607239,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"high":41.666396,"avg":3.032129,"sd":37.953208,"marketCap":2265991990},"quantilePoints":[{"date":"2020-06-19","current":-56.936338,"twenty":8.983635,"median":16.855926,"eighty":45.060758,"marketCap":4156352681},{"date":"2020-06-26","current":-55.08953,"twenty":8.930444,"median":16.855926,"eighty":45.060758,"marketCap":4021535714},{"date":"2020-07-02","current":-57.723095,"twenty":8.872607,"median":16.855926,"eighty":45.060758,"marketCap":4213785918},{"date":"2020-07-10","current":-57.093689,"twenty":8.675995,"median":16.855926,"eighty":45.060758,"marketCap":4167839328},{"date":"2020-07-17","current":-63.354616,"twenty":8.557057,"median":16.855926,"eighty":45.060758,"marketCap":4624886983},{"date":"2020-07-24","current":-64.439512,"twenty":8.367293,"median":16.855926,"eighty":45.060758,"marketCap":4704084394},{"date":"2020-07-31","current":-44.748169,"twenty":8.317859,"median":16.855926,"eighty":45.060758,"marketCap":4564313264},{"date":"2020-08-07","current":-47.060277,"twenty":8.104676,"median":16.855926,"eighty":45.060758,"marketCap":4800148210},{"date":"2020-08-14","current":-45.655227,"twenty":7.849302,"median":16.855926,"eighty":45.060758,"marketCap":4656833127},{"date":"2020-08-21","current":-44.599957,"twenty":7.651738,"median":16.855926,"eighty":45.060758,"marketCap":4549195639},{"date":"2020-08-28","current":-44.718527,"twenty":7.25977,"median":16.855926,"eighty":45.060758,"marketCap":4561289739},{"date":"2020-09-04","current":-44.196821,"twenty":6.363575,"median":16.855926,"eighty":45.060758,"marketCap":4508075700},{"date":"2020-09-11","current":-43.260121,"twenty":6.075417,"median":16.855926,"eighty":45.060758,"marketCap":4412532312},{"date":"2020-09-18","current":-42.133709,"twenty":5.834015,"median":16.855926,"eighty":45.060758,"marketCap":4297638363},{"date":"2020-09-25","current":-41.013227,"twenty":5.699102,"median":16.855926,"eighty":45.060758,"marketCap":4183349120},{"date":"2020-10-02","current":-42.044782,"twenty":5.471088,"median":16.855926,"eighty":45.060758,"marketCap":4288567789},{"date":"2020-10-09","current":-44.101965,"twenty":5.216092,"median":16.855926,"eighty":45.060758,"marketCap":4498400420},{"date":"2020-10-16","current":-45.258019,"twenty":4.885092,"median":16.855926,"eighty":45.060758,"marketCap":4616317893},{"date":"2020-10-23","current":-44.754098,"twenty":4.479735,"median":16.855926,"eighty":45.060758,"marketCap":4564917969},{"date":"2020-10-30","current":-41.363007,"twenty":-40.555548,"median":16.855926,"eighty":45.060758,"marketCap":4219026715},{"date":"2020-11-06","current":-44.754098,"twenty":-41.328622,"median":16.855926,"eighty":45.060758,"marketCap":4564917969},{"date":"2020-11-13","current":-9.712181,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4933788013},{"date":"2020-11-20","current":-9.201515,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4674369572},{"date":"2020-11-27","current":-9.108247,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4626989343},{"date":"2020-12-04","current":-8.938913,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4540967808},{"date":"2020-12-11","current":-9.025329,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4584867159},{"date":"2020-12-18","current":-9.373926,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4761954621},{"date":"2020-12-24","current":-9.457494,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4804407095},{"date":"2020-12-31","current":-9.455107,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4803194167},{"date":"2021-01-08","current":-10.356446,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":5261074419},{"date":"2021-01-15","current":-10.145138,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":5153730307},{"date":"2021-01-22","current":-10.225125,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":5194363389},{"date":"2021-01-29","current":-9.549419,"twenty":-41.685517,"median":16.84568,"eighty":45.060758,"marketCap":4851104816},{"date":"2021-02-05","current":-10.650636,"twenty":-41.685517,"median":16.798842,"eighty":45.060758,"marketCap":5154907958},{"date":"2021-02-12","current":-10.819853,"twenty":-41.685517,"median":16.763713,"eighty":45.060758,"marketCap":5236808932},{"date":"2021-02-19","current":-10.931411,"twenty":-41.685517,"median":16.727121,"eighty":45.060758,"marketCap":5290802907},{"date":"2021-02-26","current":-10.544092,"twenty":-41.685517,"median":16.708151,"eighty":45.060758,"marketCap":5103340678},{"date":"2021-03-05","current":-10.893807,"twenty":-41.766144,"median":16.655852,"eighty":45.067329,"marketCap":5272602691},{"date":"2021-03-12","current":-11.366361,"twenty":-41.766144,"median":16.626772,"eighty":45.067329,"marketCap":5501318743},{"date":"2021-03-19","current":-11.074305,"twenty":-41.766144,"median":16.605449,"eighty":45.067329,"marketCap":5359963729},{"date":"2021-03-26","current":-11.298674,"twenty":-41.685517,"median":16.565507,"eighty":45.060758,"marketCap":5468558354},{"date":"2021-04-01","current":-11.32625,"twenty":-41.685517,"median":16.544159,"eighty":45.032615,"marketCap":5481905179},{"date":"2021-04-09","current":-11.130711,"twenty":-41.766144,"median":16.513421,"eighty":45.025182,"marketCap":5387264054},{"date":"2021-04-16","current":-11.373882,"twenty":-41.766144,"median":16.49824,"eighty":44.88663,"marketCap":5504958787},{"date":"2021-04-23","current":-11.615799,"twenty":-41.766144,"median":16.458163,"eighty":44.798223,"marketCap":5622046845},{"date":"2021-04-30","current":37.652621,"twenty":-41.766144,"median":16.458163,"eighty":44.763306,"marketCap":5233714269},{"date":"2021-05-07","current":38.556703,"twenty":-41.766144,"median":16.48927,"eighty":44.763306,"marketCap":5359381692},{"date":"2021-05-14","current":38.897371,"twenty":-41.766144,"median":16.508117,"eighty":44.763306,"marketCap":5406734634},{"date":"2021-05-21","current":38.897371,"twenty":-41.766144,"median":16.532217,"eighty":44.763306,"marketCap":5406734634},{"date":"2021-05-28","current":41.421813,"twenty":-41.766144,"median":16.539302,"eighty":44.763306,"marketCap":5757632076},{"date":"2021-06-04","current":41.177231,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5723635092},{"date":"2021-06-11","current":40.923913,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5688423930},{"date":"2021-06-18","current":38.067538,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5291387724},{"date":"2021-06-25","current":38.72267,"twenty":-41.766144,"median":16.559996,"eighty":44.763306,"marketCap":5382451074},{"date":"2021-07-02","current":38.32959,"twenty":-41.766144,"median":16.589527,"eighty":44.763306,"marketCap":5327813064},{"date":"2021-07-09","current":38.399471,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5337526488},{"date":"2021-07-16","current":37.713766,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5242213515},{"date":"2021-07-23","current":38.233504,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5314457106},{"date":"2021-07-30","current":28.544675,"twenty":-41.766144,"median":16.63409,"eighty":44.763306,"marketCap":5166586254},{"date":"2021-08-06","current":28.329928,"twenty":-41.766144,"median":16.642592,"eighty":44.763306,"marketCap":5127716909},{"date":"2021-08-13","current":29.118455,"twenty":-41.766144,"median":16.707431,"eighty":44.763306,"marketCap":5270440286},{"date":"2021-08-20","current":28.051427,"twenty":-41.766144,"median":16.798988,"eighty":44.763306,"marketCap":5077308227},{"date":"2021-08-27","current":29.259383,"twenty":-41.766144,"median":16.876011,"eighty":44.763306,"marketCap":5295948294},{"date":"2021-09-03","current":31.51759,"twenty":-41.685517,"median":16.928602,"eighty":44.762757,"marketCap":5704683753},{"date":"2021-09-10","current":31.051184,"twenty":-41.685517,"median":16.94157,"eighty":44.762757,"marketCap":5620264394},{"date":"2021-09-17","current":30.272724,"twenty":-41.685517,"median":16.987677,"eighty":44.762757,"marketCap":5479363017},{"date":"2021-09-24","current":31.121649,"twenty":-41.685517,"median":16.987677,"eighty":44.762757,"marketCap":5633018398},{"date":"2021-10-01","current":30.59149,"twenty":-41.685517,"median":19.684212,"eighty":44.762757,"marketCap":5537059701},{"date":"2021-10-08","current":31.071317,"twenty":-41.685517,"median":19.787677,"eighty":44.762757,"marketCap":5623908395},{"date":"2021-10-15","current":32.124923,"twenty":-41.685517,"median":19.83941,"eighty":44.762757,"marketCap":5814611120},{"date":"2021-10-22","current":32.826209,"twenty":-41.685517,"median":19.917009,"eighty":44.762757,"marketCap":5941543826},{"date":"2021-10-29","current":32.21552,"twenty":-41.604889,"median":19.999764,"eighty":44.762207,"marketCap":5831009125},{"date":"2021-11-05","current":32.916806,"twenty":-41.604889,"median":20.15896,"eighty":44.762207,"marketCap":5957941831},{"date":"2021-11-12","current":29.342491,"twenty":-41.604889,"median":20.28364,"eighty":44.762207,"marketCap":6455347984},{"date":"2021-11-19","current":30.162391,"twenty":-41.604889,"median":20.500749,"eighty":44.762207,"marketCap":6635726039},{"date":"2021-11-26","current":26.923508,"twenty":-41.604889,"median":20.528215,"eighty":44.762207,"marketCap":5923171764},{"date":"2021-12-03","current":26.411959,"twenty":-41.604889,"median":20.552965,"eighty":44.762207,"marketCap":5810630932},{"date":"2021-12-10","current":27.165993,"twenty":-41.604889,"median":20.676932,"eighty":44.762207,"marketCap":5976518382},{"date":"2021-12-17","current":26.837476,"twenty":-41.604889,"median":20.708356,"eighty":44.762207,"marketCap":5904244736},{"date":"2021-12-23","current":26.982334,"twenty":-41.604889,"median":20.728755,"eighty":44.762207,"marketCap":5936113430},{"date":"2021-12-31","current":27.848893,"twenty":-41.604889,"median":20.764302,"eighty":44.762207,"marketCap":6126756513},{"date":"2022-01-07","current":26.876277,"twenty":-41.524262,"median":20.796751,"eighty":44.761658,"marketCap":5912780993},{"date":"2022-01-14","current":27.341891,"twenty":-41.524262,"median":20.868148,"eighty":44.761658,"marketCap":6015216083},{"date":"2022-01-21","current":25.013821,"twenty":-41.524262,"median":20.917445,"eighty":44.761658,"marketCap":5503040636},{"date":"2022-01-28","current":24.677544,"twenty":-41.524262,"median":20.980342,"eighty":44.761658,"marketCap":5429059738},{"date":"2022-02-04","current":25.572734,"twenty":-41.443634,"median":21.023702,"eighty":44.761108,"marketCap":5421419569},{"date":"2022-02-11","current":25.553938,"twenty":-41.443634,"median":21.065338,"eighty":44.761108,"marketCap":5417434905},{"date":"2022-02-18","current":25.494866,"twenty":-41.443634,"median":21.115412,"eighty":44.761108,"marketCap":5404911676},{"date":"2022-02-25","current":25.29617,"twenty":-41.443634,"median":21.157984,"eighty":44.761108,"marketCap":5362788089},{"date":"2022-03-04","current":23.572347,"twenty":-41.443634,"median":21.240692,"eighty":44.761108,"marketCap":4997337504},{"date":"2022-03-11","current":23.66901,"twenty":-41.443634,"median":21.332705,"eighty":44.761108,"marketCap":5017830061},{"date":"2022-03-18","current":25.352557,"twenty":-41.443634,"median":21.402701,"eighty":44.761108,"marketCap":5374742080},{"date":"2022-03-25","current":26.448071,"twenty":-41.443634,"median":21.507199,"eighty":44.761108,"marketCap":5606991049},{"date":"2022-04-01","current":26.544734,"twenty":-41.443634,"median":21.611248,"eighty":44.761108,"marketCap":5627483605},{"date":"2022-04-08","current":26.703154,"twenty":-41.443634,"median":21.681627,"eighty":44.761108,"marketCap":5661068628},{"date":"2022-04-14","current":28.520955,"twenty":-41.443634,"median":21.86021,"eighty":44.761108,"marketCap":6046442530},{"date":"2022-04-22","current":27.734226,"twenty":-41.443634,"median":22.114023,"eighty":44.761108,"marketCap":5879655893},{"date":"2022-04-29","current":5.98168,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5724467780},{"date":"2022-05-06","current":5.79477,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5545595204},{"date":"2022-05-13","current":5.627805,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5385809640},{"date":"2022-05-20","current":5.695617,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5450705483},{"date":"2022-05-27","current":6.155649,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5890955748},{"date":"2022-06-03","current":6.053281,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5792989652},{"date":"2022-06-10","current":5.809521,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5559711268},{"date":"2022-06-17","current":5.398352,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5166223136},{"date":"2022-06-24","current":5.835537,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5584608729},{"date":"2022-07-01","current":5.86325,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5611129938},{"date":"2022-07-08","current":5.737128,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5490431377},{"date":"2022-07-15","current":5.58499,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5344835356},{"date":"2022-07-22","current":5.922634,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5667961098},{"date":"2022-07-29","current":5.951187,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5439385116},{"date":"2022-08-05","current":6.14725,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5618586516},{"date":"2022-08-12","current":6.304219,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5762055916},{"date":"2022-08-19","current":6.275787,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5736069006},{"date":"2022-08-26","current":6.098679,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5574192212},{"date":"2022-09-02","current":5.884253,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5378207598},{"date":"2022-09-09","current":6.054846,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5534129059},{"date":"2022-09-16","current":5.848121,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5345182567},{"date":"2022-09-23","current":5.752755,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5258018139},{"date":"2022-09-30","current":5.625403,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5141618438},{"date":"2022-10-07","current":5.617703,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5134580316},{"date":"2022-10-14","current":5.641396,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5156236075},{"date":"2022-10-21","current":5.922755,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5413398206},{"date":"2022-10-28","current":6.27401,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5734444824},{"date":"2022-11-04","current":5.909724,"twenty":-41.524262,"median":21.695313,"eighty":44.761658,"marketCap":5401487538},{"date":"2022-11-11","current":6.292902,"twenty":-41.524262,"median":21.556282,"eighty":44.761658,"marketCap":5833519919},{"date":"2022-11-18","current":6.534105,"twenty":-41.524262,"median":9.134384,"eighty":44.761658,"marketCap":6057115624},{"date":"2022-11-25","current":6.524573,"twenty":-41.524262,"median":9.120072,"eighty":44.761658,"marketCap":6048278877},{"date":"2022-12-02","current":6.634386,"twenty":-41.524262,"median":9.077138,"eighty":44.761658,"marketCap":6150076230},{"date":"2022-12-09","current":6.425327,"twenty":-41.524262,"median":9.031818,"eighty":44.761658,"marketCap":5956278049},{"date":"2022-12-16","current":6.216944,"twenty":-41.524262,"median":8.981727,"eighty":44.761658,"marketCap":5763107329},{"date":"2022-12-23","current":6.332842,"twenty":-41.524262,"median":8.929251,"eighty":44.761658,"marketCap":5870544977},{"date":"2022-12-30","current":6.29421,"twenty":-41.524262,"median":8.870812,"eighty":44.761658,"marketCap":5834732428},{"date":"2023-01-06","current":6.238017,"twenty":-41.524262,"median":8.723665,"eighty":44.669031,"marketCap":5782641447},{"date":"2023-01-13","current":6.570492,"twenty":-41.524262,"median":8.558011,"eighty":44.528495,"marketCap":6090846415},{"date":"2023-01-20","current":6.436448,"twenty":-41.524262,"median":8.531792,"eighty":44.433823,"marketCap":5966587722},{"date":"2023-01-27","current":6.301234,"twenty":-41.524262,"median":8.3296,"eighty":44.14834,"marketCap":5841243800},{"date":"2023-02-03","current":6.219087,"twenty":-40.702575,"median":8.3296,"eighty":44.14834,"marketCap":5715340826},{"date":"2023-02-10","current":6.142315,"twenty":-11.558641,"median":8.3296,"eighty":44.14834,"marketCap":5644787763},{"date":"2023-02-17","current":6.10452,"twenty":-11.342294,"median":8.3296,"eighty":44.14834,"marketCap":5610053948},{"date":"2023-02-24","current":6.038378,"twenty":-11.297421,"median":8.3296,"eighty":44.14834,"marketCap":5549269770},{"date":"2023-03-03","current":6.122827,"twenty":-11.1811,"median":8.3296,"eighty":44.14834,"marketCap":5626878140},{"date":"2023-03-10","current":5.75019,"twenty":-11.13773,"median":8.3296,"eighty":44.14834,"marketCap":5284424426},{"date":"2023-03-17","current":5.610229,"twenty":-11.066032,"median":8.3296,"eighty":44.14834,"marketCap":5155800765},{"date":"2023-03-24","current":5.809835,"twenty":-10.976285,"median":8.3296,"eighty":44.14834,"marketCap":5339238729},{"date":"2023-03-31","current":6.065544,"twenty":-10.897567,"median":8.324965,"eighty":44.139273,"marketCap":5574234700},{"date":"2023-04-06","current":5.988772,"twenty":-10.820856,"median":8.324965,"eighty":44.139273,"marketCap":5503681637},{"date":"2023-04-14","current":6.134638,"twenty":-10.775982,"median":8.3296,"eighty":44.14834,"marketCap":5637732457},{"date":"2023-04-21","current":6.151764,"twenty":-10.730374,"median":8.3296,"eighty":44.14834,"marketCap":5653471217},{"date":"2023-04-27","current":5.856489,"twenty":-10.606264,"median":8.340928,"eighty":44.166474,"marketCap":5382113282},{"date":"2023-05-05","current":20.861975,"twenty":-10.43882,"median":8.452838,"eighty":44.175541,"marketCap":4693944269},{"date":"2023-05-12","current":20.287633,"twenty":-10.336151,"median":8.558011,"eighty":44.182524,"marketCap":4564717446},{"date":"2023-05-19","current":21.14158,"twenty":-10.102877,"median":8.693871,"eighty":44.189507,"marketCap":4756855455},{"date":"2023-05-26","current":20.227136,"twenty":-9.78508,"median":8.870812,"eighty":44.196491,"marketCap":4551105489},{"date":"2023-06-02","current":19.892072,"twenty":-9.536436,"median":8.929251,"eighty":44.196491,"marketCap":4475716188},{"date":"2023-06-09","current":20.206194,"twenty":-9.454384,"median":8.98113,"eighty":44.203474,"marketCap":4546393658},{"date":"2023-06-16","current":20.073565,"twenty":-9.376314,"median":9.018699,"eighty":44.210457,"marketCap":4516552059},{"date":"2023-06-23","current":19.475569,"twenty":-9.301666,"median":9.056863,"eighty":44.224123,"marketCap":4382003099},{"date":"2023-06-29","current":19.508145,"twenty":-9.246426,"median":9.092642,"eighty":44.237789,"marketCap":4389332615},{"date":"2023-07-05","current":20.315555,"twenty":-9.193781,"median":9.114705,"eighty":44.251456,"marketCap":4570999888},{"date":"2023-07-14","current":20.455165,"twenty":-9.060547,"median":9.163604,"eighty":44.278788,"marketCap":4602412096},{"date":"2023-07-20","current":21.216038,"twenty":-8.93818,"median":19.183552,"eighty":44.278788,"marketCap":4773608633},{"date":"2023-07-28","current":19.591649,"twenty":4.319692,"median":19.750135,"eighty":44.283744,"marketCap":4682404042},{"date":"2023-08-04","current":19.289348,"twenty":4.38581,"median":19.591649,"eighty":44.129229,"marketCap":4610154209},{"date":"2023-08-11","current":19.13927,"twenty":4.38581,"median":19.482306,"eighty":43.956729,"marketCap":4574285498},{"date":"2023-08-18","current":18.466062,"twenty":4.38581,"median":19.154278,"eighty":43.542383,"marketCap":4413388708},{"date":"2023-08-25","current":18.088722,"twenty":4.38581,"median":18.641868,"eighty":43.319191,"marketCap":4323204519},{"date":"2023-08-31","current":18.781226,"twenty":4.38581,"median":18.466062,"eighty":42.973946,"marketCap":4488713001},{"date":"2023-09-08","current":17.87218,"twenty":4.380867,"median":18.294543,"eighty":42.623722,"marketCap":4271451093},{"date":"2023-09-13","current":17.293307,"twenty":4.378395,"median":18.166977,"eighty":42.388429,"marketCap":4133100350},{"date":"2023-09-22","current":18.005107,"twenty":4.319692,"median":17.86146,"eighty":42.077012,"marketCap":4303220523},{"date":"2023-09-29","current":17.479833,"twenty":4.263461,"median":17.50556,"eighty":41.816324,"marketCap":4177680034},{"date":"2023-10-06","current":17.087485,"twenty":4.263461,"median":17.293307,"eighty":41.73771,"marketCap":4083908975},{"date":"2023-10-13","current":16.418565,"twenty":4.263461,"median":16.945983,"eighty":41.577207,"marketCap":3924037005},{"date":"2023-10-20","current":16.294214,"twenty":4.207231,"median":16.495748,"eighty":41.332109,"marketCap":3894317216},{"date":"2023-10-27","current":16.257767,"twenty":-1.056217,"median":16.28671,"eighty":41.192954,"marketCap":3885606243},{"date":"2023-11-03","current":16.332806,"twenty":-6.207204,"median":16.153784,"eighty":40.948113,"marketCap":3903540598},{"date":"2023-11-10","current":15.616718,"twenty":-6.207204,"median":15.881499,"eighty":40.817223,"marketCap":3732395605},{"date":"2023-11-17","current":16.390693,"twenty":-6.207204,"median":15.574911,"eighty":40.340898,"marketCap":3917375673},{"date":"2023-11-24","current":22.827913,"twenty":-6.207204,"median":15.574911,"eighty":39.96161,"marketCap":4063368468},{"date":"2023-12-01","current":23.015098,"twenty":-8.782697,"median":15.533103,"eighty":39.312288,"marketCap":4096687371},{"date":"2023-12-07","current":23.654406,"twenty":-6.207204,"median":15.574911,"eighty":38.926597,"marketCap":4210484243},{"date":"2023-12-15","current":24.893249,"twenty":-8.782697,"median":15.533103,"eighty":38.72267,"marketCap":4430998377},{"date":"2023-12-22","current":24.325418,"twenty":-8.782697,"median":15.533103,"eighty":38.648421,"marketCap":4329924480},{"date":"2023-12-29","current":24.225549,"twenty":-8.789917,"median":12.47951,"eighty":38.641433,"marketCap":4312147664},{"date":"2024-01-05","current":22.661874,"twenty":-8.797137,"median":9.425916,"eighty":38.597758,"marketCap":4033813516},{"date":"2024-01-12","current":23.423737,"twenty":-8.797137,"median":9.425916,"eighty":38.470225,"marketCap":4169425227},{"date":"2024-01-19","current":22.447867,"twenty":-8.804357,"median":9.30281,"eighty":38.332211,"marketCap":3995720339},{"date":"2024-01-26","current":22.718942,"twenty":-8.797137,"median":9.425916,"eighty":38.217781,"marketCap":4043971696},{"date":"2024-02-02","current":28.85349,"twenty":-8.797137,"median":9.425916,"eighty":38.049194,"marketCap":4731972377},{"date":"2024-02-09","current":27.918791,"twenty":-8.797137,"median":9.425916,"eighty":37.903318,"marketCap":4578681720},{"date":"2024-02-16","current":28.325049,"twenty":-8.797137,"median":9.425916,"eighty":37.631656,"marketCap":4645308051},{"date":"2024-02-23","current":28.413632,"twenty":-8.797137,"median":9.425916,"eighty":37.11978,"marketCap":4659835597},{"date":"2024-03-01","current":28.603015,"twenty":-8.789917,"median":12.47951,"eighty":32.879225,"marketCap":4690894489},{"date":"2024-03-08","current":29.339167,"twenty":-8.789917,"median":12.47951,"eighty":32.536971,"marketCap":4811623405},{"date":"2024-03-15","current":29.363604,"twenty":-8.789917,"median":12.47951,"eighty":32.258469,"marketCap":4815631004},{"date":"2024-03-22","current":29.357495,"twenty":-8.789917,"median":12.47951,"eighty":31.941046,"marketCap":4814629104},{"date":"2024-03-28","current":29.81568,"twenty":-8.789917,"median":12.47951,"eighty":31.40619,"marketCap":4889771583},{"date":"2024-04-05","current":29.122292,"twenty":-8.797137,"median":9.425916,"eighty":31.117622,"marketCap":4776055965},{"date":"2024-04-12","current":29.372767,"twenty":-8.797137,"median":9.425916,"eighty":31.051184,"marketCap":4817133853},{"date":"2024-04-19","current":29.168111,"twenty":-8.797137,"median":9.425916,"eighty":30.606254,"marketCap":4783570213},{"date":"2024-04-26","current":29.079528,"twenty":-8.789917,"median":12.47951,"eighty":30.256618,"marketCap":4769042667},{"date":"2024-05-03","current":24.879315,"twenty":-8.789917,"median":12.47951,"eighty":29.945905,"marketCap":4801707860},{"date":"2024-05-10","current":25.416952,"twenty":-8.789917,"median":12.47951,"eighty":29.757033,"marketCap":4905471669},{"date":"2024-05-17","current":25.614345,"twenty":-8.789917,"median":12.47951,"eighty":29.613467,"marketCap":4943568527},{"date":"2024-05-24","current":25.463703,"twenty":-8.789917,"median":12.47951,"eighty":29.5169,"marketCap":4914494609},{"date":"2024-05-31","current":25.87667,"twenty":-8.789917,"median":12.47951,"eighty":29.365437,"marketCap":4994197245},{"date":"2024-06-07","current":26.035104,"twenty":-8.789917,"median":12.47951,"eighty":29.342276,"marketCap":5024774986},{"date":"2024-06-14","current":25.292282,"twenty":-8.797137,"median":9.425916,"eighty":29.274986,"marketCap":4881410496},{"date":"2024-06-21","current":25.066319,"twenty":-8.804357,"median":9.30281,"eighty":29.230424,"marketCap":4837799620},{"date":"2024-06-28","current":24.487127,"twenty":-8.826676,"median":9.172548,"eighty":29.168722,"marketCap":4726015420},{"date":"2024-07-05","current":24.193634,"twenty":-8.826676,"median":9.172548,"eighty":29.132067,"marketCap":4669371408},{"date":"2024-07-12","current":24.601407,"twenty":-8.826676,"median":9.172548,"eighty":29.097856,"marketCap":4748071495},{"date":"2024-07-15","current":24.596212,"twenty":-8.826676,"median":9.172548,"eighty":29.090525,"marketCap":4747068946},{"date":"2024-08-02","current":24.957234,"twenty":-8.929025,"median":9.114705,"eighty":28.735731,"marketCap":4816746093},{"date":"2024-08-09","current":27.237695,"twenty":-8.929025,"median":9.114705,"eighty":28.677936,"marketCap":4058416549},{"date":"2024-08-16","current":27.91282,"twenty":-8.929025,"median":9.114705,"eighty":28.593851,"marketCap":4159010197},{"date":"2024-08-23","current":28.407693,"twenty":-8.929025,"median":9.114705,"eighty":28.535286,"marketCap":4232746318},{"date":"2024-08-30","current":29.413827,"twenty":-8.929025,"median":9.114705,"eighty":28.535286,"marketCap":4382660153},{"date":"2024-09-06","current":28.273324,"twenty":-8.929025,"median":9.114705,"eighty":28.515633,"marketCap":4212725252},{"date":"2024-09-13","current":27.91282,"twenty":-8.929025,"median":9.114705,"eighty":28.437936,"marketCap":4159010197},{"date":"2024-09-20","current":28.840298,"twenty":-8.929025,"median":9.114705,"eighty":28.414125,"marketCap":4297204384},{"date":"2024-09-27","current":28.584668,"twenty":-8.929025,"median":9.114705,"eighty":28.410315,"marketCap":4259115526},{"date":"2024-10-04","current":27.693241,"twenty":-8.929025,"median":9.114705,"eighty":28.328952,"marketCap":4126292846},{"date":"2024-10-11","current":27.781728,"twenty":-8.929025,"median":9.114705,"eighty":28.174035,"marketCap":4139477450},{"date":"2024-10-18","current":28.768197,"twenty":-8.929025,"median":9.114705,"eighty":28.155826,"marketCap":4286461373},{"date":"2024-10-25","current":27.847274,"twenty":-8.929025,"median":9.114705,"eighty":28.143107,"marketCap":4149243823},{"date":"2024-10-31","current":28.55845,"twenty":-8.929025,"median":9.114705,"eighty":28.102675,"marketCap":4255208977},{"date":"2024-11-08","current":23.317939,"twenty":-8.93818,"median":9.109339,"eighty":27.987673,"marketCap":3940731747},{"date":"2024-11-15","current":22.552233,"twenty":-8.93818,"median":9.109339,"eighty":27.96198,"marketCap":3811327297},{"date":"2024-11-22","current":21.642415,"twenty":-8.93818,"median":9.127228,"eighty":27.96083,"marketCap":3657568070},{"date":"2024-11-29","current":21.759491,"twenty":-8.93818,"median":9.172548,"eighty":27.96083,"marketCap":3677353987},{"date":"2024-12-06","current":21.310698,"twenty":-8.93818,"median":16.14628,"eighty":27.96083,"marketCap":3601507972},{"date":"2024-12-13","current":20.66399,"twenty":-8.93818,"median":16.326374,"eighty":27.96083,"marketCap":3492214336},{"date":"2024-12-20","current":20.056308,"twenty":-8.93818,"median":16.418565,"eighty":27.96083,"marketCap":3389516005},{"date":"2024-12-27","current":20.109271,"twenty":-8.93818,"median":16.564355,"eighty":27.96083,"marketCap":3398466777},{"date":"2025-01-03","current":19.440263,"twenty":-8.93818,"median":16.920255,"eighty":27.96083,"marketCap":3285404395},{"date":"2025-01-10","current":19.6399,"twenty":-8.938327,"median":17.089629,"eighty":27.96106,"marketCap":3319143109},{"date":"2025-01-17","current":19.75157,"twenty":-8.938327,"median":17.49484,"eighty":27.96106,"marketCap":3338015281},{"date":"2025-01-24","current":20.086579,"twenty":-8.938327,"median":17.759622,"eighty":27.96106,"marketCap":3394631794},{"date":"2025-01-31","current":-136.701619,"twenty":-9.032373,"median":17.86146,"eighty":27.96106,"marketCap":3007435623},{"date":"2025-02-07","current":-139.725612,"twenty":-9.144874,"median":17.86146,"eighty":27.96106,"marketCap":3073963459},{"date":"2025-02-14","current":-139.361017,"twenty":-9.245709,"median":17.86146,"eighty":27.96106,"marketCap":3065942372},{"date":"2025-02-21","current":-140.326121,"twenty":-9.301666,"median":17.86146,"eighty":27.96106,"marketCap":3087174660},{"date":"2025-02-28","current":-131.897546,"twenty":-9.377985,"median":17.86146,"eighty":27.96106,"marketCap":2901746013},{"date":"2025-03-07","current":-127.90845,"twenty":-9.455107,"median":17.87218,"eighty":27.96129,"marketCap":2813985889},{"date":"2025-03-14","current":-119.994597,"twenty":-9.579026,"median":17.87218,"eighty":27.96129,"marketCap":2639881128},{"date":"2025-03-21","current":-119.823023,"twenty":-9.954842,"median":17.87218,"eighty":27.96129,"marketCap":2636106499},{"date":"2025-03-28","current":-128.144364,"twenty":-10.210799,"median":17.87218,"eighty":27.96129,"marketCap":2819176004},{"date":"2025-04-04","current":-113.839378,"twenty":-10.377935,"median":17.87218,"eighty":27.96129,"marketCap":2504466314},{"date":"2025-04-11","current":-104.209785,"twenty":-10.499986,"median":17.86146,"eighty":27.96106,"marketCap":2292615264},{"date":"2025-04-17","current":-106.268673,"twenty":-10.617545,"median":17.86146,"eighty":27.96106,"marketCap":2337910812},{"date":"2025-04-25","current":-114.482781,"twenty":-10.734618,"median":17.87218,"eighty":27.96129,"marketCap":2518621173},{"date":"2025-05-02","current":-19.826576,"twenty":-10.796539,"median":17.87218,"eighty":27.96129,"marketCap":2240403051},{"date":"2025-05-09","current":-20.214777,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2284269804},{"date":"2025-05-16","current":-20.890086,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2360579678},{"date":"2025-05-23","current":-20.234996,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2286554531},{"date":"2025-05-30","current":-20.590847,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2326765722},{"date":"2025-06-06","current":-20.040895,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2264621154},{"date":"2025-06-13","current":-20.894129,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2361036623},{"date":"2025-06-16","current":-20.053026,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2265991990}],"updateTime":1750209381472}}}